With 90% efficacy against Covid-19, Pfizer/BioNTech’s vaccine jumps ahead in global race

November 9, 2020 Auto Bot AstraZeneca, BioNTech, BioPharma, biopharma nl, Emergency Use Authorization, Food and Drug Administration, Germany, Johnson & Johnson, New York City, News, Pfizer, Pharma, Policy, Vaccines 0

Finish line ahead

The news sent the stock market soaring as it represents a key milestone in developing and distributing a vaccine for the virus. Still public confidence in vaccines need to be boosted, an expert noted.